Suzanne Hendrix

Suzanne Hendrix is founder and CEO of Pentara Corporation, a specialty CRO focusing on data management and statistics in Alzheimer’s and other degenerative diseases. She received her PhD from Boston University and has over 35 years of clinical trials experience including regulatory submissions, across a broad range of indications for drugs, biologics and devices. Pentara has had integral involvement in over 80 AD clinical trials of all phases with input into study design, data collection and analysis for small, medium and large pharmaceutical companies, non-profit groups and academic groups. She received her PhD from Boston University and has over 30 years of clinical trials experience including dozens of regulatory submissions, across a broad range of indications for both drugs and devices. Suzanne is an author of over 200 peer-reviewed publications and scientific presentations related to clinical trial results and statistical approaches for clinical trials, in AD and other degenerati